v3.26.1
Commitments, Contingencies, and Concentration Risk (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 21, 2026
USD ($)
Feb. 16, 2026
May 15, 2023
USD ($)
robot
May 12, 2023
USD ($)
robot
Jan. 01, 2022
USD ($)
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2025
Jun. 30, 2026
USD ($)
robot
shares
Jun. 30, 2025
Dec. 31, 2025
USD ($)
Jan. 09, 2023
USD ($)
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Company owes services (in Dollars) $ 845,891                    
Settlement agreement description   On February 16, 2026, the Company entered into a settlement agreement to fully settle the Encompass Purchase liability for an aggregate amount of $650,000. The settlement consists of (i) a cash payment of $50,000, (ii) issuance of Company shares with an aggregate fair value of $400,000, and (iii) assignment of a loan liability of $200,000. The Company paid $50,000 per the settlement agreement and recognized a loan liability of $200,000 during the six months ended June 30, 2026. The issuance of Company shares with an aggregate fair value of $400,000 remains pending as of June 30, 2026.                  
Encompass purchase liability (in Dollars)           $ 400,000   $ 400,000   $ 650,000  
Plan provides initial shares equal (in Shares) | shares               2,553,403      
Interest rate           15.00%   15.00%      
Excise tax payable (in Dollars)           $ 0   $ 0   1,200,000  
Purchase Agreement for Telepresence Robots [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Number of robots purchased (in robot) | robot               20      
Total purchase commitment (in Dollars)               $ 711,900      
Unpaid commitment amount (in Dollars)           $ 179,900   $ 179,900   $ 179,900  
Percentage of monthly revenue generated from telepresence robots, considered for payment       80.00%              
Telepresence robots deployed (in robot) | robot               8      
Total number of deployed telepresence robots (in robot) | robot       11              
Number of robots for which lifetime use payments is to be made (in robot) | robot               125      
Amount paid by investor (in Dollars)       $ 352,000              
Equity Incentive Plan 2024 [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Percentage of shares reserved for issuance               15.00%      
Number of shares issued (in Shares) | shares           2,544,021   2,544,021      
Customer Concentration Risk [Member] | Three Customers [Member] | Accounts Receivable [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Concentration risk percentage               23.00%   43.00%  
Customer Concentration Risk [Member] | One Customer [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Concentration risk percentage           46.00% 29.00% 43.00% 28.00%    
Supplier Concentration Risk [Member] | Accounts Payable and Accrued Liability [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Concentration risk percentage               78.00%   31.00%  
Two Vendor [Member] | Supplier Concentration Risk [Member] | Accounts Payable and Accrued Liability [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Number of suppliers               2   2  
Investor [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Number of deployed telepresence robots rights held (in robot) | robot               8      
Percentage of monthly revenue generated from telepresence robots, considered for payment               80.00%      
Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Aggregate principal amount (in Dollars)     $ 200,000     $ 200,000   $ 200,000      
Number of deployed telepresence robots rights held (in robot) | robot     8                
Percentage of monthly revenue generated from telepresence robots, considered for payment     80.00%                
Telepresence robots deployed (in robot) | robot     8         8      
Encompass Healthcare Billing, LLC [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Business acquisition percentage of voting interests acquired         100.00%            
Encompass for a cash payment (in Dollars)         $ 300,000            
Interest expense (in Dollars)                     $ 45,000
Encompass purchase liability (in Dollars)           $ 400,000   $ 400,000   $ 650,000  
Minimum [Member] | Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Total number of deployed telepresence robots (in robot) | robot     12         13      
Maximum [Member] | Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                      
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                      
Total number of deployed telepresence robots (in robot) | robot     20         20